Skip to main content
H.R. 7658 117th Congress House

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Introduced: May 3, 2022 See on congress.gov
Health
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 3, 2022
Referred to the House Committee on Energy and Commerce.
May 3, 2022
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 3, 2022

Referred to the House Committee on Energy and Commerce.

 Plain-English summary Congressional Research Service

This bill reauthorizes through FY2027 the Food and Drug Administration's Critical Path Public-Private Partnerships, which support medical product innovation, development, and safety.

 Related & companion bills 3
  • S 4152 Identical bill A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
  • HR 7667 Food and Drug Amendments of 2022
  • S 4348 FDASLA Act of 2022
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 7658: To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.. 117th Congress. Open America. https://openamerica.io/bill/117-HR-7658/
MLA
"H.R. 7658: To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-7658/.
Bluebook (legal)
H.R. 7658, 117th Cong. (2026), https://openamerica.io/bill/117-HR-7658/.
Markdown link
[H.R. 7658: To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.](https://openamerica.io/bill/117-HR-7658/)
Report a problem